AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9620911
Drug: Placebo (vehicle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (vehicle inhalation)
Trial: 2668247
Drug: Netilmicin 4.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Netilmicin 4.5 mg/kg once daily (od)
Trial: 2668247
Drug: Netilmicin 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Netilmicin 1.5 mg/kg thrice daily (tid)
Trial: 29415833
Drug: l-arginine (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l-arginine (6 g/day for 7 days)
Trial: 24839047
Drug: Sublingual fentanyl
RxNorm normalized name: fentanyl Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual fentanyl orally disintegrating tablet
Trial: 23816726
Drug: Eradication treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eradication treatment for Helicobacter pylori infection
Trial: 11333069
Drug: Electroconvulsive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroconvulsive therapy (ECT) with varying electrode placement and stimulus intensity; lorazepam PRN (3 mg/day) was allowed.
Trial: 11333069
Drug: Electroconvulsive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroconvulsive therapy (ECT) with unilateral or bilateral application.
Trial: 11333069
Drug: Electroconvulsive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroconvulsive therapy (ECT) for bipolar patients (BP I and BP II).
Trial: 8507109
Drug: Regular oral
RxNorm normalized name: infant formula,regular ORAL PACKET (EA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular oral diet (Control)
Trial: 2435356
Drug: Phenoxybenzamine 10
RxNorm normalized name: phenoxybenzamine 10 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenoxybenzamine 10 mg/day for 5 weeks
Trial: 24698126
Drug: Local heat
RxNorm normalized name: norethindrone
DrugBank: Norethisterone (DB00717)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Local heat therapy (hot pack warmed to 50 °C)
Trial: 24698126
Drug: Placebo heat
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo heat therapy (hot pack warmed to 37 °C)
Trial: 21234866
Drug: BCG plus
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCG plus prulifloxacin (600 mg single oral dose 6 hours after instillation)
Trial: 12819631
Drug: Herbal ointment
RxNorm normalized name: Hyperici herba
DrugBank: St. John's Wort (DB01323)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herbal ointment applied to affected joint(s) for 42 days
Trial: 12819631
Drug: Sham ointment
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham ointment applied to affected joint(s) for 42 days
Trial: 12819631
Drug: Herbal ointment
RxNorm normalized name: Hyperici herba
DrugBank: St. John's Wort (DB01323)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herbal ointment
Trial: 8061263
Drug: pipecuronium (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pipecuronium (0.15 mg/kg)
Trial: 8061263
Drug: doxacurium (0.08
FDA approved: no
EMA approved: no
PMDA approved: no
Description: doxacurium (0.08 mg/kg)
Trial: 2456424
Drug: Operation plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Operation plus preoperative and postoperative therapy with cisplatin, vindesine, and bleomycin (n = 19)
Trial: 2456424
Drug: Patients responding
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients responding to chemotherapy preoperatively
Trial: 2456424
Drug: Nonresponders to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonresponders to chemotherapy
Trial: 30829209
Drug: Candicure (polyherbal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candicure (polyherbal formulation)
Trial: 30829209
Drug: Fluconazole therapy
RxNorm normalized name: Fluconazole
DrugBank: Fluconazole (DB00196)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluconazole therapy (control drug)
Trial: 25966264
Drug: Ginkgo biloba
RxNorm normalized name: Ginkgo Biloba
DrugBank: Ginkgo biloba (DB01381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginkgo biloba tablets (GBT) 19.2 mg three times a day for 3 months along with conventional anti-platelet aggregation treatment
Trial: 25966264
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment with 75 mg aspirin three times a day for 3 months
Trial: 25966264
Drug: Ginkgo biloba
RxNorm normalized name: Ginkgo Biloba
DrugBank: Ginkgo biloba (DB01381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginkgo biloba tablets (GBT)
Trial: 22398345
Drug: Iyengar yoga
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iyengar yoga program (twice-weekly classes for 8 weeks)
Trial: 22398345
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (usual daily routines)
Trial: 8739145
Drug: Palatal plate
RxNorm normalized name: malate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palatal plate therapy
Trial: 11370751
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no palatal plate therapy)
Trial: 9212478
Drug: Oral controlled-release
RxNorm normalized name: Afeditab CR
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral controlled-release morphine (MST)
Trial: 3663878
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of adinazolam (40 mg)
Trial: 3663878
Drug: Steady-state dosing
RxNorm normalized name: CLOZAPINE (GOLDEN STATE)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steady-state dosing of adinazolam (final dose rates of 1, 2, and 3 mg h‐1)
Trial: 29364091
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy of Lamivudine (LAM) and Adefovir Dipivoxil (ADV)
Trial: 29364091
Drug: 12-week optimized
RxNorm normalized name: risedronate
DrugBank: Risedronic acid (DB00884)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 12-week optimized therapy of Adefovir Dipivoxil (ADV) after Lamivudine (LAM)
Trial: 29364091
Drug: 24-week optimized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24-week optimized therapy of Adefovir Dipivoxil (ADV) after Lamivudine (LAM)
Trial: 29364091
Drug: Combination therapy,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy, 12-week optimized therapy, and ETV monotherapy
Trial: 25530151
Drug: Cocoa flavanols
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocoa flavanols (CF) 1.4-10.9 mg/kg bw
Trial: 25530151
Drug: Inorganic nitrate
RxNorm normalized name: Organic germanium
DrugBank: Propagermanium (DB17608)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inorganic nitrate 0.1-10 mg/kg bw
Trial: 25530151
Drug: Nitrate (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrate (3 or 8.5 mg/kg bw) followed by CF (2.7 or 10.9 mg/kg bw)
Trial: 21610559
Drug: High-volume wound
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-volume wound infiltration with ropivacaine 0.2% with epinephrine (10 μg/mL)
Trial: 16972834
Drug: Tramadol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol (2 mg.kg‐1 tramadol in 0.2 ml.kg‐1 saline)
Trial: 16972834
Drug: Bupivacaine (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine (0.2 ml.kg‐1 0.25% bupivacaine)
Trial: 16972834
Drug: Intramuscular tramadol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular tramadol (2 mg.kg‐1 tramadol injected 20 minutes before end of surgery)
Trial: 10908213
Drug: Bosentan (50,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bosentan (50, 150, and 300 mg administered at 2-hour intervals)
Trial: 9156659
Drug: GM-CSF (molgramostim)
RxNorm normalized name: axatilimab-csfr
DrugBank: Regramostim (DB05386)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GM-CSF (molgramostim) 8 mg/kg/d for 14 days
Trial: 7798818
Drug: Morphine slow
RxNorm normalized name: Slow Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine slow release tablet (MST)
Trial: 7798818
Drug: Morphine sulphate
RxNorm normalized name: Morphine sulphate
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Morphine sulphate solution (MSS)
Trial: 24678979
Drug: Evolocumab (420
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evolocumab (420 mg) every 4 weeks
Trial: 24678979
Drug: Evolocumab (420
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evolocumab (420 mg) with background therapy of diet alone
Trial: 24678979
Drug: Evolocumab (420
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evolocumab (420 mg) with background therapy of atorvastatin 10 mg
Trial: 24678979
Drug: Evolocumab (420
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evolocumab (420 mg) with background therapy of atorvastatin 80 mg
Trial: 24678979
Drug: Evolocumab (420
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evolocumab (420 mg) with background therapy of atorvastatin 80 mg plus ezetimibe 10 mg
Trial: 8147547
Drug: Low-dose dopamine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose dopamine (3 micrograms/kg per minute)
Trial: 16575844
Drug: Integrated Treatment
RxNorm normalized name: Bag Spike + Integrated Clave
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrated Treatment (IT)
Trial: 24597469
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual (Control Group)
Trial: 20565953
Drug: Drugs in
RxNorm normalized name: Other antiobesity drugs in ATC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drugs in reverse order (Arm B)
Trial: 17407241
Drug: TNF-blocking drug
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TNF-blocking drug
Trial: 10695094
Drug: amoxycillin/clavulanate 875/125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: amoxycillin/clavulanate 875/125 mg twice daily
Trial: 10695094
Drug: amoxycillin/clavulanate 500/125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: amoxycillin/clavulanate 500/125 mg three times daily
Trial: 8620702
Drug: BAY u3405
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAY u3405 (75 mg orally, twice a day for 2 weeks)
Trial: 8620702
Drug: Placebo (oral,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (oral, twice a day for 2 weeks)
Trial: 6285241
Drug: Ifosfamide monotherapy
RxNorm normalized name: Ifosfamide
DrugBank: Ifosfamide (DB01181)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ifosfamide monotherapy
Trial: 6285241
Drug: Symptomatic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Symptomatic therapy (control group)
Trial: 27830365
Drug: Haloperidol (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (5 mg) administered daily during postoperative days 0-5
Trial: 22000309
Drug: Valproate (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valproate (20 mg/kg)
Trial: 22000309
Drug: Valproate (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valproate (20 mg/kg) with diazepam
Trial: 22000309
Drug: Phenytoin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenytoin (20 mg/kg) with diazepam
Trial: 19016706
Drug: Tacalcitol ointment
RxNorm normalized name: tacalcitol
DrugBank: Tacalcitol (DB13689)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tacalcitol ointment plus sunlight exposure
Trial: 19016706
Drug: Vehicle (placebo)
RxNorm normalized name: meningococcal group B vaccine / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle Prefilled Syringe [Bexsero]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle (placebo) ointment plus sunlight exposure
Trial: 11422014
Drug: Sinistrin (2500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sinistrin (2500 mg, intravenous)
Trial: 11422014
Drug: p-Aminohippuric acid
RxNorm normalized name: p-aminohippuric acid
DrugBank: Aminohippuric acid (DB00345)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: p-Aminohippuric acid (PAH; 440 mg, intravenous)
Trial: 11422014
Drug: Rac-pindolol (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rac-pindolol (15 mg, oral)
Trial: 11422014
Drug: S-pindolol (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-pindolol (15 mg, oral)
Trial: 11422014
Drug: Fluconazole (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluconazole (100 mg, oral)
Trial: 8536521
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of CCK (24 pmol/kg/hr)
Trial: 6990334
Drug: Early treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early treatment with antimicrobials (cefamandole) starting preoperatively and continuing for 4 days
Trial: 6990334
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (treatment only if infection was apparent)
Trial: 23728174
Drug: Exenatide (subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exenatide (subcutaneous injection for 12 months)
Trial: 12788888
Drug: 1 implant
RxNorm normalized name: LEUPROLIDE ACETATE 72 MILLIGRAM In 1 IMPLANT SUBCUTANEOUS IMPLANT [Viadur]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 implant of MENT (400 microg/d x implant)
Trial: 12788888
Drug: 2 implants
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 implants of MENT (400 microg/d x implant)
Trial: 10825322
Drug: Fentanyl infusion
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl infusion at 1.5 ng/mL
Trial: 10825322
Drug: Fentanyl infusion
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl infusion at 3.0 ng/mL
Trial: 10825322
Drug: Fentanyl infusion
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl infusion at 4.5 ng/mL
Trial: 6363158
Drug: Diproderm cream
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diproderm cream 0.05%, applied twice a day
Trial: 6363158
Drug: Diproderm cream
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diproderm cream 0.05%, applied once a day
Trial: 22795613
Drug: IV morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV morphine alone
Trial: 22795613
Drug: IV morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV morphine and IV oxycodone (0.75 mg each)
Trial: 22795613
Drug: IV morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV morphine plus IV oxycodone (0.5 mg/0.5 mg) via PCA
Trial: 22795613
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg IV morphine alone via PCA
Trial: 17519714
Drug: 2.5 ml
RxNorm normalized name: syringe, disposable, 2.5 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 ml 0.75% ropivacaine
Trial: 17519714
Drug: 2.5 ml
RxNorm normalized name: syringe, disposable, 2.5 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 ml 2% lidocaine
Trial: 8451009
Drug: Aspartame 600
RxNorm normalized name: Aspartame
DrugBank: Aspartame (DB00168)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspartame 600 mg
Trial: 8451009
Drug: Aspartame 1200
RxNorm normalized name: Aspartame
DrugBank: Aspartame (DB00168)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspartame 1200 mg
Trial: 31317843
Drug: Radically Open
RxNorm normalized name: BOTTLE OPENER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radically Open Dialectical Behaviour Therapy (RO DBT) plus Treatment as Usual (TAU)
Trial: 31317843
Drug: Radically Open
RxNorm normalized name: BOTTLE OPENER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radically Open Dialectical Behaviour Therapy (RO DBT)
Trial: 31127381
Drug: Aflibercept injections
RxNorm normalized name: Aflibercept
DrugBank: Aflibercept (DB08885)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Aflibercept injections alone (Group A)
Trial: 31127381
Drug: Aflibercept injections
RxNorm normalized name: Aflibercept
DrugBank: Aflibercept (DB08885)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Aflibercept injections followed by micropulsed laser (Group B)
Trial: 24706354
Drug: Cognitive-behavioral conjoint
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral conjoint therapy for PTSD
Trial: 21823174
Drug: Group music
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group music intervention using percussion instruments with familiar music, 30-min sessions, twice weekly for 6 weeks
Trial: 15366327
Drug: Isosorbide-5-mononitrate prolonged-release
RxNorm normalized name: Isosorbide 5-mononitrate
DrugBank: Isosorbide mononitrate (DB01020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide-5-mononitrate prolonged-release tablet formulation (60 mg)
Trial: 10995136
Drug: Continuous propofol
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuous propofol administration
Trial: 1637600
Drug: Isoflurane administration
RxNorm normalized name: Isoflurane
DrugBank: Isoflurane (DB00753)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isoflurane administration
Trial: 23920422
Drug: MK-0249 (5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK-0249 (5, 8, 10, or 12 mg)
Trial: 21995156
Drug: Topical lipohydroperoxides
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical lipohydroperoxides and glycyrrhetic acid for three days (n = 50)
Trial: 21995156
Drug: Vaginal antibacterial
RxNorm normalized name: Dermoplast Antibacterial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal antibacterial metronidazole (500 mg) or antimycotic econazole (150 mg) for six days (n = 50)
Trial: 21995156
Drug: Topical lipohydroperoxides
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical lipohydroperoxides and glycyrrhetic acid
Trial: 19337019
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine (IG) + repaglinide
Trial: 19337019
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine (IG) + acarbose
Trial: 15475831
Drug: losartan (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: losartan (50 mg/d)
Trial: 14999200
Drug: captopril (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: captopril (50 mg 3 times/d)
Trial: 10705305
Drug: r‐IL‐2 therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: r‐IL‐2 therapy (12 M IU/m2/day continuous infusion on day 1‐5, 15‐17, 29‐31, 43‐45 and 57‐59)
Trial: 10705305
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no r‐IL‐2 therapy)
Trial: 9158540
Drug: Frequent quizzes
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Frequent quizzes administered at the beginning of each class (Quiz Group - QG)
Trial: 1540458
Drug: Three cotton
RxNorm normalized name: Cotton
DrugBank: Cotton (DB10707)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three cotton swabs soaked in 4% lignocaine solution
Trial: 25451347
Drug: Arformoterol (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arformoterol (15 μg bid)
Trial: 22342501
Drug: Intanza(®) 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intanza(®) 15 μg intradermal vaccine
Trial: 22342501
Drug: Intramuscular (IM)
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular (IM) Vaxigrip(®) vaccine
Trial: 18541078
Drug: Dexamethasone (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (2 ml) plus ondansetron 4 mg (2 ml)
Trial: 18541078
Drug: Dexamethasone 8
RxNorm normalized name: dexamethasone 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 8 mg (2 ml) and normal saline (2 ml)
Trial: 16183940
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for thromboembolic disease
Trial: 14569216
Drug: Nonsurgical treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonsurgical treatments for sciatica
Trial: 8565536
Drug: Magnesium sulfate
RxNorm normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Magnesium sulfate (2 g, 8 mmol)
Trial: 1759835
Drug: Org 10172
RxNorm normalized name: ORG-34517
DrugBank: ORG-34517 (DB05423)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org 10172 (intravenous bolus injection of 3,250 anti‐Xa units) + cloxacillin (500 mg orally four times daily for 3 days)
Trial: 1759835
Drug: Org 10172
RxNorm normalized name: ORG-34517
DrugBank: ORG-34517 (DB05423)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org 10172 (intravenous bolus injection of 3,250 anti‐Xa units) + ticarcillin (4,000 mg intravenously four times daily for 2 days)
Trial: 7058755
Drug: Sulfinpyrazone (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfinpyrazone (800 mg/day)